Treatment with Tnf-α-ASO (TJU-2755), which is delivered into kupffer cells by galactosylated low molecular weight chitosan, alleviates the symptoms of severe hepatitis in mice (Dong et al., 2009). This evidence concerns the gene TNF and hepatitis A virus infection.